TradingMarkets’ 6 Stocks You Need To Know About Today
Genentech
reported Q2 earnings of 0.30 vs a 0.26 forecast; revenues were in-line.
Herceptin sales rose 23%. Tarceva sales were $10 million higher than analysts
expected. DNA is up nearly $40 in the past 4 months. The company upped its
guidance.
Pepsi
(
PEP |
Quote |
Chart |
News |
PowerRating) beat by 0.03 and said it was confident in its 2005
outlook.
Ameritrade
(
AMTD |
Quote |
Chart |
News |
PowerRating) beat by a penny, beat on revenues and issued
in-line guidance.
Bank of America upgraded Dreamworks
(
DWA |
Quote |
Chart |
News |
PowerRating) to buy.
Biomet
(
BMET |
Quote |
Chart |
News |
PowerRating) was upgraded at Morgan Stanley, to overweight.
Colgate
(
CL |
Quote |
Chart |
News |
PowerRating) is selling its U.S. laundry brands for $60 million and
will repatriate in $800 million in Q3, resulting in a one-time $35 million
charge.